Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 198

    1.

    Progression of age-related macular degeneration after cataract surgery.

    Dong LM, Stark WJ, Jefferys JL, Al-Hazzaa S, Bressler SB, Solomon SD, Bressler NM.

    Arch Ophthalmol. 2009 Nov;127(11):1412-9.PMID: 19901205 [PubMed - indexed for MEDLINE]Related articles

    2.

    A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators.

    N Engl J Med. 2009 Nov 19;361(21):2019-32. Epub 2009 Oct 30.PMID: 19880844 [PubMed - in process]Related articles

    3.

    Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.

    Piccini JP, Zhang M, Pieper K, Solomon SD, Al-Khatib SM, Van de Werf F, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ.

    Eur Heart J. 2009 Oct 23. [Epub ahead of print]PMID: 19854729 [PubMed - as supplied by publisher]Related articles

    4.

    Predictors of heart failure in patients with stable coronary artery disease: a PEACE study.

    Lewis EF, Solomon SD, Jablonski KA, Rice MM, Clemenza F, Hsia J, Maggioni AP, Zabalgoitia M, Huynh T, Cuddy TE, Gersh BJ, Rouleau J, Braunwald E, Pfeffer MA; PEACE Investigators.

    Circ Heart Fail. 2009 May;2(3):209-16. Epub 2009 Apr 14.PMID: 19808342 [PubMed - indexed for MEDLINE]Related articles

    5.

    Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group.

    Submacular Surgery Trials Research Group, Solomon SD, Jefferys JL, Hawkins BS, Bressler NM, Bressler SB.

    Retina. 2009 Sep;29(8):1080-90.PMID: 19734762 [PubMed - in process]Related articles

    6.

    Cardiac-resynchronization therapy for the prevention of heart-failure events.

    Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators.

    N Engl J Med. 2009 Oct 1;361(14):1329-38. Epub 2009 Sep 1.PMID: 19723701 [PubMed - indexed for MEDLINE]Related articles

    7.

    Albuminuria in chronic heart failure: prevalence and prognostic importance.

    Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ; CHARM Investigators and Committees.

    Lancet. 2009 Aug 15;374(9689):543-50.PMID: 19683640 [PubMed - indexed for MEDLINE]Related articles

    8.

    EXCEED: Exforge(R) - intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale,design, and participant characteristics.

    Hassanein A, Desai A, Verma A, Oparil S, Izzo J, Rocha R, Hilkert R, Seifu Y, Pitt B, Solomon SD.

    Ther Adv Cardiovasc Dis. 2009 Jul 28. [Epub ahead of print]PMID: 19638366 [PubMed - as supplied by publisher]Related articles

    9.

    Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.

    McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Polu KR, Solomon SD, Sun Y, Swedberg K, Tendera M, van Veldhuisen DJ, Wasserman SM, Young JB; RED-HF Committees and Investigators.

    Eur J Heart Fail. 2009 Aug;11(8):795-801.PMID: 19633103 [PubMed - in process]Related articles

    10.

    Therapeutic approaches to diastolic dysfunction.

    Janardhanan R, Desai AS, Solomon SD.

    Curr Hypertens Rep. 2009 Aug;11(4):283-91.PMID: 19602330 [PubMed - in process]Related articles

    11.

    Dual renin-angiotensin system blockade and kidney disease.

    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Pfeffer MA.

    J Am Coll Cardiol. 2009 Jul 14;54(3):278-9; author reply 279-80. No abstract available. PMID: 19589445 [PubMed - indexed for MEDLINE]Related articles

    12.

    Echocardiographic imaging in clinical trials: American Society of Echocardiography Standards for echocardiography core laboratories: endorsed by the American College of Cardiology Foundation.

    Douglas PS, DeCara JM, Devereux RB, Duckworth S, Gardin JM, Jaber WA, Morehead AJ, Oh JK, Picard MH, Solomon SD, Wei K, Weissman NJ; American Society of Echocardiography Standards; American College of Cardiology Foundation.

    J Am Soc Echocardiogr. 2009 Jul;22(7):755-65. No abstract available. PMID: 19560654 [PubMed - indexed for MEDLINE]Related articles

    13.

    Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.

    Moukarbel GV, Signorovitch JE, Pfeffer MA, McMurray JJ, White HD, Maggioni AP, Velazquez EJ, Califf RM, Scheiman JM, Solomon SD.

    Eur Heart J. 2009 Sep;30(18):2226-32. Epub 2009 Jun 25.PMID: 19556260 [PubMed - in process]Related articles

    14.

    Risk factors for rhegmatogenous retinal detachment in the submacular surgery trials: SST report No. 22.

    Solomon SD, Dong LM, Haller JA, Gilson MM, Hawkins BS, Bressler NM; SST research group and the SST adverse event review committee.

    Retina. 2009 Jun;29(6):819-24.PMID: 19516120 [PubMed - indexed for MEDLINE]Related articles

    15.

    Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill J, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, Uno H; TREAT Investigators.

    Am J Kidney Dis. 2009 Jul;54(1):59-69. Epub 2009 Jun 5.PMID: 19501439 [PubMed - indexed for MEDLINE]Related articles

    16.

    Diastolic dysfunction as a link between hypertension and heart failure.

    Verma A, Solomon SD.

    Med Clin North Am. 2009 May;93(3):647-64. Review.PMID: 19427497 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.

    Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD.

    JACC Cardiovasc Imaging. 2008 Sep;1(5):582-91.PMID: 19356485 [PubMed - indexed for MEDLINE]Related articles

    18.

    Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT).

    Berry C, Pieper KS, White HD, Solomon SD, Van de Werf F, Velazquez EJ, Maggioni AP, Califf RM, Pfeffer MA, McMurray JJ.

    Eur Heart J. 2009 Jun;30(12):1450-6. Epub 2009 Apr 3.PMID: 19346225 [PubMed - indexed for MEDLINE]Related articles

    19.

    Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

    Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, Swedberg K, Pfeffer MA, McMurray JJ, Maggioni AP; Valsartan in Acute Myocardial Infarction Trial Investigators.

    Eur J Heart Fail. 2009 Mar;11(3):292-8. Epub 2009 Jan 27.PMID: 19176539 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.

    Solomon SD, Appelbaum E, Manning WJ, Verma A, Berglund T, Lukashevich V, Cherif Papst C, Smith BA, Dahlöf B; Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators.

    Circulation. 2009 Feb 3;119(4):530-7. Epub 2009 Jan 19.PMID: 19153265 [PubMed - indexed for MEDLINE]Related articles

    21.

    Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.

    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.

    Nephrol Dial Transplant. 2009 May;24(5):1663-71. Epub 2009 Jan 14.PMID: 19145003 [PubMed - indexed for MEDLINE]Related articles

    22.

    Recalibrating the barometer: is it time to take a critical look at noninvasive approaches to measuring filling pressures?

    Solomon SD, Stevenson LW.

    Circulation. 2009 Jan 6;119(1):13-5. Epub 2008 Dec 15. No abstract available. PMID: 19075101 [PubMed - indexed for MEDLINE]Related articles

    23.

    Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.

    Meredith PA, Ostergren J, Anand I, Puu M, Solomon SD, Michelson EL, Olofsson B, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, McMurray JJ.

    J Am Coll Cardiol. 2008 Dec 9;52(24):2000-7.PMID: 19055992 [PubMed - indexed for MEDLINE]Related articles

    24.

    Early use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: evidence from clinical trials.

    Moukarbel GV, Solomon SD.

    Curr Heart Fail Rep. 2008 Dec;5(4):197-203. Review.PMID: 19032914 [PubMed - indexed for MEDLINE]Related articles

    25.

    Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).

    Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ.

    Am J Cardiol. 2008 Dec 1;102(11):1427-32. Epub 2008 Sep 11.PMID: 19026290 [PubMed - indexed for MEDLINE]Related articles

    26.

    Treatment of asymptomatic left ventricular dysfunction.

    Moukarbel GV, Solomon SD.

    Curr Treat Options Cardiovasc Med. 2008 Dec;10(6):476-85.PMID: 19026178 [PubMed - in process]Related articles

    27.

    Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure.

    Abrahamsson P, Dobson J, Granger CB, McMurray JJ, Michelson EL, Pfeffer M, Pocock S, Solomon SD, Yusuf S, Swedberg K; CHARM Investigators.

    Eur Heart J. 2009 Feb;30(3):338-45. Epub 2008 Nov 11.PMID: 19001475 [PubMed - indexed for MEDLINE]Related articles

    28.

    Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.

    Meris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L, Bourgoun M, McMurray JJ, Velazquez EJ, Maggioni AP, Ghali J, Arnold JM, Zelenkofske S, Pfeffer MA, Solomon SD.

    Eur Heart J. 2009 Jan;30(1):56-65. Epub 2008 Nov 11.PMID: 19001474 [PubMed - indexed for MEDLINE]Related articles

    29.

    Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme.

    Cohen-Solal A, McMurray JJ, Swedberg K, Pfeffer MA, Puu M, Solomon SD, Michelson EL, Yusuf S, Granger CB; CHARM Investigators.

    Eur Heart J. 2008 Dec;29(24):3022-8. Epub 2008 Nov 5.PMID: 18987098 [PubMed - indexed for MEDLINE]Related articles

    30.

    Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.

    Vardeny O, Solomon SD.

    Cardiol Clin. 2008 Nov;26(4):589-601.PMID: 18929233 [PubMed - indexed for MEDLINE]Related articles

    31.

    Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.

    Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB.

    Eur Heart J. 2008 Nov;29(21):2641-50. Epub 2008 Sep 26.PMID: 18819960 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.

    McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J; Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators.

    Circ Heart Fail. 2008 May;1(1):17-24.PMID: 19808266 [PubMed - indexed for MEDLINE]

    33.

    Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

    MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ; CHARM Investigators.

    Eur Heart J. 2008 Jun;29(11):1377-85. Epub 2008 Apr 14.PMID: 18413309 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Accidental Nd:YAG laser-induced choroidal neovascularization.

    Ying HS, Symons RC, Lin KL, Solomon SD, Gehlbach PL.

    Lasers Surg Med. 2008 Apr;40(4):240-2.PMID: 18412221 [PubMed - indexed for MEDLINE]Related articles

    35.

    Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis.

    Solomon SD, Wittes J, Finn PV, Fowler R, Viner J, Bertagnolli MM, Arber N, Levin B, Meinert CL, Martin B, Pater JL, Goss PE, Lance P, Obara S, Chew EY, Kim J, Arndt G, Hawk E; Cross Trial Safety Assessment Group.

    Circulation. 2008 Apr 22;117(16):2104-13. Epub 2008 Mar 31.PMID: 18378608 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Mapping directions for the cardiorenal conundrum: where you end up depends upon where you started, so where do we go from here?

    Weinrauch LA, Lin J, Solomon SD.

    J Am Coll Cardiol. 2008 Apr 1;51(13):1275-6. No abstract available. PMID: 18371558 [PubMed - indexed for MEDLINE]Related articles

    37.

    High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.

    Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD.

    Am Heart J. 2008 Apr;155(4):706-11. Epub 2008 Jan 31.PMID: 18371480 [PubMed - indexed for MEDLINE]Related articles

    38.

    Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.

    Campochiaro PA, Hafiz G, Shah SM, Nguyen QD, Ying H, Do DV, Quinlan E, Zimmer-Galler I, Haller JA, Solomon SD, Sung JU, Hadi Y, Janjua KA, Jawed N, Choy DF, Arron JR.

    Mol Ther. 2008 Apr;16(4):791-9. Epub 2008 Feb 5.PMID: 18362932 [PubMed - indexed for MEDLINE]Related articles

    39.

    Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.

    Anavekar NS, Solomon SD, McMurray JJ, Maggioni A, Rouleau JL, Califf R, White H, Kober L, Velazquez E, Pfeffer MA.

    Am J Cardiol. 2008 Apr 1;101(7):925-9.PMID: 18359309 [PubMed - indexed for MEDLINE]Related articles

    40.

    Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.

    Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA.

    Eur Heart J. 2008 Mar;29(6):748-56. Epub 2008 Feb 28.PMID: 18308687 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).

    Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, McMurray JJ, Velazquez E, Califf R, Pfeffer MA, Solomon SD.

    Am J Cardiol. 2008 Mar 1;101(5):607-12.PMID: 18308007 [PubMed - indexed for MEDLINE]Related articles

    42.

    Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project.

    Bressler SB, Muñoz B, Solomon SD, West SK; Salisbury Eye Evaluation (SEE) Study Team.

    Arch Ophthalmol. 2008 Feb;126(2):241-5.PMID: 18268216 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.

    Weir RA, McMurray JJ, Puu M, Solomon SD, Olofsson B, Granger CB, Yusuf S, Michelson EL, Swedberg K, Pfeffer MA; CHARM Investigators.

    Eur J Heart Fail. 2008 Feb;10(2):157-63. Epub 2008 Jan 31.PMID: 18242128 [PubMed - indexed for MEDLINE]Related articles

    44.

    Optimizing care of heart failure after acute MI with an aldosterone receptor antagonist.

    Verma A, Solomon SD.

    Curr Heart Fail Rep. 2007 Dec;4(4):183-9. Review.PMID: 18221614 [PubMed - indexed for MEDLINE]Related articles

    45.

    Vitamin usage patterns in the prevention of advanced age-related macular degeneration.

    Charkoudian LD, Gower EW, Solomon SD, Schachat AP, Bressler NM, Bressler SB.

    Ophthalmology. 2008 Jun;115(6):1032-1038.e4. Epub 2007 Dec 21.PMID: 18096234 [PubMed - indexed for MEDLINE]Related articles

    46.

    Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.

    Thomas KL, Al-Khatib SM, Lokhnygina Y, Solomon SD, Kober L, McMurray JJ, Califf RM, Velazquez EJ.

    Am Heart J. 2008 Jan;155(1):87-93. Epub 2007 Oct 25.PMID: 18082495 [PubMed - indexed for MEDLINE]Related articles

    47.

    Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease.

    Solomon SD, Lin J, Solomon CG, Jablonski KA, Rice MM, Steffes M, Domanski M, Hsia J, Gersh BJ, Arnold JM, Rouleau J, Braunwald E, Pfeffer MA; Prevention of Events With ACE Inhibition (PEACE) Investigators.

    Circulation. 2007 Dec 4;116(23):2687-93. Epub 2007 Nov 19.PMID: 18025537 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.

    Thune JJ, Signorovitch J, Kober L, Velazquez EJ, McMurray JJ, Califf RM, Maggioni AP, Rouleau JL, Howlett J, Zelenkofske S, Pfeffer MA, Solomon SD.

    Hypertension. 2008 Jan;51(1):48-54. Epub 2007 Nov 19.PMID: 18025296 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.

    Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA; CHARM Program Investigators.

    J Am Coll Cardiol. 2007 Nov 13;50(20):1959-66. Epub 2007 Oct 29.PMID: 17996561 [PubMed - indexed for MEDLINE]Related articles

    50.

    Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group.

    Submacular Surgery Trials Research Group, Solomon SD, Jefferys JL, Hawkins BS, Bressler NM.

    Arch Ophthalmol. 2007 Oct;125(10):1323-30.PMID: 17923538 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...